$2.35
0.010.43%
At Close: -
$2.35
00.00%
After Hours: Jul 26, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Standard BioTools (NASDAQ:LAB) Stock, Analyst Ratings, Price Targets, Forecasts
Standard BioTools Inc has a consensus price target of $3.58 based on the ratings of 3 analysts. The high is $4 issued by Keybanc on July 12, 2023. The low is $3.25 issued by Jefferies on April 4, 2024. The 3 most-recent analyst ratings were released by TD Cowen, Jefferies, and Keybanc on April 16, 2024, April 4, 2024, and July 12, 2023, respectively. With an average price target of $3.58 between TD Cowen, Jefferies, and Keybanc, there's an implied 52.48% upside for Standard BioTools Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Jefferies
Keybanc
1calculated from analyst ratings
Analyst Ratings for Standard BioTools
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/16/2024 | Buy Now | 48.94% | TD Cowen | Daniel Brennan | → $3.5 | Initiates | → Buy | Get Alert |
| 04/04/2024 | Buy Now | 38.3% | Jefferies | Matthew Stanton | → $3.25 | Initiates | → Buy | Get Alert |
| 07/12/2023 | Buy Now | 70.21% | Keybanc | Paul Knight | → $4 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Standard BioTools (LAB) stock?
The latest price target for Standard BioTools (NASDAQ:LAB) was reported by TD Cowen on April 16, 2024. The analyst firm set a price target for $3.50 expecting LAB to rise to within 12 months (a possible 48.94% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Standard BioTools (LAB)?
The latest analyst rating for Standard BioTools (NASDAQ:LAB) was provided by TD Cowen, and Standard BioTools initiated their buy rating.
When was the last upgrade for Standard BioTools (LAB)?
There is no last upgrade for Standard BioTools
When was the last downgrade for Standard BioTools (LAB)?
There is no last downgrade for Standard BioTools.
When is the next analyst rating going to be posted or updated for Standard BioTools (LAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Standard BioTools, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Standard BioTools was filed on April 16, 2024 so you should expect the next rating to be made available sometime around April 16, 2025.
Is the Analyst Rating Standard BioTools (LAB) correct?
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $3.50. The current price Standard BioTools (LAB) is trading at is $2.35, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.